Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 941

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

Bartelink, Harry, Horiot, Jean-Claude, Poortmans, Philip, Struikmans, Henk, Van den Bogaert, Walter, Barillot, Isabelle, Fourquet, Alain, Borger, Jacques, Jager, Jos, Hoogenraad, Willem, Collette, Laurence, Pierart, Marianne · 2001 · New England Journal of Medicine

Abstract

BACKGROUND: Radiotherapy prevents local recurrence of breast cancer after breast-conserving surgery. We evaluated the effect of a supplementary dose of radiation to the tumor bed on the rates of local recurrence among patients who received radiotherapy after breast-conserving surgery for early breast cancer. METHODS: After lumpectomy and axillary dissection, patients with stage I or II breast cancer received 50 Gy of radiation to the whole breast in 2-Gy fractions over a five-week period. Patients with a microscopically complete excision were randomly assigned to receive either no further local treatment (2657 patients) or an additional localized dose of 16 Gy, usually given in eight fractions by means of an external electron beam (2661 patients). RESULTS: During a median follow-up period of 5.1 years, local recurrences were observed in 182 of the 2657 patients in the standard-treatment group and 109 of the 2661 patients in the additional-radiation group. The five-year actuarial rates of local recurrence were 7.3 percent (95 percent confidence interval, 6.8 to 7.6 percent) and 4.3 percent (95 percent confidence interval, 3.8 to 4.7 percent), respectively (P<0.001), yielding a hazard ratio for local recurrence of 0.59 (99 percent confidence interval, 0.43 to 0.81) associated with an additional dose. Patients 40 years old or younger benefited most; at five years, their rate of local recurrence was 19.5 percent with standard treatment and 10.2 percent with additional radiation (hazard ratio, 0.46 [99 percent confidence interval, 0.23 to 0.89]; P=0.002). At five years in the age group 41 to 50 years old, no differences were found in rates of metastasis or overall survival (which were 87 and 91 percent, respectively). CONCLUSIONS: In patients with early breast cancer who undergo breast-conserving surgery and receive 50 Gy of radiation to the whole breast, an additional dose of 16 Gy of radiation to the tumor bed reduces the risk of local recurrence, especially in patients younger than 50 years of age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa010874

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, 1992:19-25. (NIH publication no. 90-3187.)
  2. 10.1093/jnci/82.4.277 · doi:10.1093/jnci/82.4.277
  3. 10.1016/0167-8140(91)90165-D · doi:10.1016/0167-8140(91)90165-d
  4. 10.1016/0167-8140(91)90163-B · doi:10.1016/0167-8140(91)90163-b
  5. 10.1016/0167-8140(91)90162-A · doi:10.1016/0167-8140(91)90162-a
  6. van Tienhoven G, 1992, Radiother Oncol, 24, S35
  7. 10.2307/2281868 · doi:10.2307/2281868 · Paper page
  8. 10.1016/S0360-3016(99)00211-4 · doi:10.1016/s0360-3016(99)00211-4
  9. 10.1016/S0167-8140(00)00210-3 · doi:10.1016/s0167-8140(00)00210-3
  10. 1998, CMAJ, 158, S35
  11. Romestaing P, 1997, J Clin Oncol, 15, 963, 10.1200/JCO.1997.15.3.963 · doi:10.1200/jco.1997.15.3.963
  12. Elkhuizen PHM, 2000, J Clin Oncol, 18, 1075, 10.1200/JCO.2000.18.5.1075 · doi:10.1200/jco.2000.18.5.1075
  13. 10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K · doi:10.1002/1097-0142(20010701)92:1<172::aid-cncr1306>3.0.co;2-k

Cited by

See all 941

Metadata

Authors
Bartelink, H., Horiot, J.-C., Poortmans, P., Struikmans, H., Van den Bogaert, W., Barillot, I., Fourquet, A., Borger, J., Jager, J., Hoogenraad, W., Collette, L., & Pierart, M.
Venue
New England Journal of Medicine
Published
2001-11-08
Volume
345
Issue
19
Pages
1378-1387
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2066920146
Cited by
941
References
22
FWCI
13.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.